---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-251239"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:24:50.804080+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tempus AI to acquire Ambry Genetics for $375M cash plus ~4.84M shares

## Summary
- Acquisition of Ambry Genetics (genetic testing) for $375M cash + 4,843,136 TEM shares valued at ~$46.46/share avg VWAP.
- Debt financing from Ares: $200M term loan + $100M revolving credit facility to fund cash consideration and fees.
- Expected close in Q1 2025 subject to HSR clearance and other customary conditions.
- Seller (Konica Minolta's REALM IDx) provides limited indemnity; Tempus obtained buyside R&W insurance policy.
- Lock-up on 2,152,505 shares of stock consideration for one year; registration rights granted for stock consideration.

## SEC filing metadata
- accession: 0001193125-24-251239
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000119312524251239/0001193125-24-251239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000119312524251239/d907265d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-251239
- JSON: https://secwatch.observer/filing/0001193125-24-251239.json
- Plain text: https://secwatch.observer/filing/0001193125-24-251239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.